Published in Invest Ophthalmol Vis Sci on January 01, 2001
Mechanisms and management of retinopathy of prematurity. N Engl J Med (2012) 3.52
Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med (2005) 1.91
Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest (2007) 1.89
Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol (2005) 1.69
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol (2005) 1.68
Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest (2010) 1.49
Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest (2003) 1.43
High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol (2008) 1.41
Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev Biol (2008) 1.11
Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci (2008) 1.10
The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest Ophthalmol Vis Sci (2009) 1.03
Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.99
MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am J Pathol (2012) 0.98
Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp Eye Res (2010) 0.97
The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model. Doc Ophthalmol (2009) 0.96
Hypoxia-induced oxidative stress in ischemic retinopathy. Oxid Med Cell Longev (2012) 0.95
Arginase in retinopathy. Prog Retin Eye Res (2013) 0.94
The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy. J Biol Chem (2011) 0.94
Arginase: an old enzyme with new tricks. Trends Pharmacol Sci (2015) 0.94
Retinal features predictive of progressive stage 4 retinopathy of prematurity. Retina (2004) 0.91
Endothelial nitric oxide synthase gene T-786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity. Mol Vis (2008) 0.89
Vascular dysfunction in retinopathy-an emerging role for arginase. Brain Res Bull (2009) 0.88
Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate. PLoS One (2010) 0.87
eNOS-beta-actin interaction contributes to increased peroxynitrite formation during hyperoxia in pulmonary artery endothelial cells and mouse lungs. J Biol Chem (2010) 0.86
Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy. Doc Ophthalmol (2009) 0.86
The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease. Antioxid Redox Signal (2014) 0.84
Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci (2010) 0.84
Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity. JAMA Ophthalmol (2013) 0.83
Novel peptide for attenuation of hyperoxia-induced disruption of lung endothelial barrier and pulmonary edema via modulating peroxynitrite formation. J Biol Chem (2014) 0.81
The effect of oxygen and light on the structure and function of the neonatal rat retina. Doc Ophthalmol (2008) 0.81
Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy. PLoS One (2014) 0.79
N-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathy. PLoS One (2011) 0.79
Bioelectric impact of pathological angiogenesis on vascular function. Proc Natl Acad Sci U S A (2016) 0.79
eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage. Invest Ophthalmol Vis Sci (2012) 0.78
Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1). Angiogenesis (2014) 0.78
Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration. PLoS One (2014) 0.78
Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis. Exp Eye Res (2016) 0.75
More weapons in the arsenal against ischemic retinopathy. J Clin Invest (2001) 0.75
ADVANCES IN UNDERSTANDING AND MANAGEMENT OF RETINOPATHY OF PREMATURITY. Surv Ophthalmol (2016) 0.75
Endothelial nitric oxide synthase gene promoter polymorphism (T-786C) may be associated with advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet (1991) 6.37
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proc Natl Acad Sci U S A (2001) 5.85
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 5.15
Evolution by the birth-and-death process in multigene families of the vertebrate immune system. Proc Natl Acad Sci U S A (1997) 4.83
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88
Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature (1995) 3.15
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation (2001) 3.01
Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A (1998) 3.00
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab (1996) 2.78
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol (1998) 2.38
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem (1999) 2.18
Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology (2000) 2.17
Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol (1999) 2.13
Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology (1995) 2.13
A conserved aspartate of tRNA pseudouridine synthase is essential for activity and a probable nucleophilic catalyst. Biochemistry (1998) 2.12
Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab (1996) 2.01
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell (1995) 1.99
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A (2000) 1.89
Determination of the number of conserved chromosomal segments between species. Genetics (2001) 1.89
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89
The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics (1999) 1.88
Retinoblastoma in transgenic mice. Nature (1990) 1.84
Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol (2001) 1.80
Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol (2000) 1.79
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol (1999) 1.74
Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci (1996) 1.73
Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol (1999) 1.72
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell (1995) 1.71
The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest (1999) 1.71
Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation (1997) 1.67
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest (1998) 1.65
The P blood group system: recent progress in immunochemistry and genetics. Semin Hematol (1981) 1.65
Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res (1997) 1.63
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation (2001) 1.63
Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell (1996) 1.61
Multiple-injection axillary brachial plexus block: A comparison of two methods of nerve localization-nerve stimulation versus paresthesia. Anesth Analg (2000) 1.57
Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science (1994) 1.56
Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant (2006) 1.55
Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol (1999) 1.54
Early metazoan divergence was about 830 million years ago. J Mol Evol (1998) 1.54
nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics (2000) 1.54
Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology (2001) 1.53
Unenhanced helical CT of ureteral stones: a replacement for excretory urography in planning treatment. AJR Am J Roentgenol (1998) 1.53
VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.53
Is there a role for ginger in the treatment of osteoarthritis? Arthritis Rheum (2001) 1.53
Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science (1969) 1.52
Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract (2002) 1.52
New self-expanding patent foramen ovale occlusion device. Catheter Cardiovasc Interv (1999) 1.50
A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J Cell Biol (1996) 1.50
Posterior segment complications after vitrectomy for macular hole. Ophthalmology (1995) 1.47
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke (2001) 1.47
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J (2001) 1.44
Balance and physical impairments after stroke. Arch Phys Med Rehabil (1999) 1.42
Immunochemical properties of glycolipids and phospholipids. Adv Immunol (1976) 1.41
Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res (1999) 1.41
Does the myocardium become "stunned" after episodes of angina at rest, angina on effort, and coronary angioplasty? Am J Cardiol (1993) 1.40
The haemodynamics of the distal arterial Y-shaped autograft bypass-flap in a porcine experimental model. Eur J Vasc Endovasc Surg (2008) 1.40
Renal artery embolization with diluted hot contrast medium: an experimental study. J Vasc Interv Radiol (2001) 1.40
Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med (1999) 1.38
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci (1997) 1.38
Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes. Proc Natl Acad Sci U S A (1976) 1.37
Vitamin D administration to tuberculous children and its value. Boll Chim Farm (1998) 1.37
Sex differences in mutation rate in higher primates estimated from AMG intron sequences. J Mol Evol (1997) 1.36
On reporting fold differences. Pac Symp Biocomput (2001) 1.36
Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. J Clin Invest (1996) 1.35
Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J Natl Cancer Inst (1975) 1.35
Striatal origin of the pathologic beta oscillations in Parkinson's disease. Proc Natl Acad Sci U S A (2011) 1.35
Retracted Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J (2007) 1.34
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J Biol Chem (2000) 1.33
Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol (1989) 1.32
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet (1984) 1.31
Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation (2001) 1.31
Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol (2012) 1.31
Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc Natl Acad Sci U S A (1999) 1.30
MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett (1990) 1.30
The crystal structure of a high oxygen affinity species of haemoglobin (bar-headed goose haemoglobin in the oxy form). J Mol Biol (1996) 1.30
Identification of a novel virus in pigs--Bungowannah virus: a possible new species of pestivirus. Virus Res (2007) 1.30
Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J Biol Chem (1999) 1.28
ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol (1996) 1.26
Estimating the distribution of worm burden and egg excretion of Schistosoma japonicum by risk group in Sichuan Province, China. Parasitology (2002) 1.26
Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol (2000) 1.25
Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles. Physiol Genomics (2001) 1.25
Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.25
DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. J Pathol (2007) 1.24
Evolutionary patterns of gene families generated in the early stage of vertebrates. J Mol Evol (2000) 1.24
Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab (1999) 1.23
Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene (1995) 1.22
Patterns of biosynthesis and accumulation of hydrocarbons and contact sex pheromone in the female German cockroach, Blattella germanica. Arch Insect Biochem Physiol (1994) 1.22